CordenPharma
Stephan Haitz is an accomplished executive in the commercial sector of the pharmaceutical and biotechnology industries, currently serving as Chief Commercial Officer at Corden Pharma since June 2024. Prior to this role, Stephan held the position of President at Axplora for a brief tenure from November 2023 to June 2024. From February 2014 to October 2022, Stephan was with Cambrex, progressing through various leadership roles including President of Drug Substance CDMO Commercial and President of CDMO Sales & Marketing. Earlier experience includes key positions at Lonza as Sales Director for Europe Bioscience Solutions and Head of Business Development for Formulated Products in India & Africa, as well as Executive Vice President of Marketing & Sales at Solvias AG. Educational credentials include a Doctorate in Chemistry from The University of Freiburg and a Bachelor of Science in Business Administration from FernUniversität in Hagen.
This person is not in any teams
This person is not in any offices
CordenPharma
1 followers
CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of cGMP facilities across Europe and the US organized under six technology platforms – Peptides, Lipids & Carbohydrates, Oligonucleotides, Injectables, Highly Potent & Oncology, Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value pharmaceutical products. Visit to learn more > cordenpharma.com